Here are relevant reports on : rapid-dna-analysis-market

• Bottled Water Testing Equipment Market by Technology (Traditional, and Rapid), Component (Instruments, Consumables & Reagents, and Reference Material), Test Type (Microbiological, Chemical, Physical, Radiological), and Region - Global Forecast to 2021

  The bottled water testing equipment market, in terms of value, is projected to reach USD 6.46 Billion by 2021, at a CAGR of 5.3% from 2016. Rapid increase in consumption of bottled water, rise in disposable income, awareness about the effects of health due to contaminated water, increase in regulations regarding bottled water quality, and technological developments in the water testing industry are some of the factors driving this market.

  • Published: September 2016
  • Price: $ 4950
  • TOC Available:

• Malaria Diagnostics Market by Technology (Microscopy, Rapid Diagnostic Tests, Molecular Diagnostic Tests), End User (Hospitals, Clinics, Diagnostics Centers, and Others), and Geography - Global Forecast to 2027

  The global malaria diagnostics market size is projected to reach USD 1.02 Billion by 2027 from USD 770.5 million in 2022, at a CAGR of 5.4% during the forecast period. Market is driven by factors such as rise in the prevalence of malaria in developing countries. Moreover, the surge in awareness initiatives by governments and the increase in research for new malaria diagnostics are the factors that boost the growth of this market. However, lack of alertness about healthcare in developing countries is a major factor that restricts the malaria diagnostics market growth.

  • Published: March 2026
  • Price: $ 4950
  • TOC Available:

• Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region - Global Forecast to 2026

  The enteric disease testing market is expected to reach USD 2.4 billion by 2026, it is projected to grow at a CAGR of 6.0% during the forecasting period. Key players in this market include SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia), and TÜV SÜD (Germany). Key players in this market are focusing on increasing their presence through mergers & acquisitions and new product developments, specific to consumer tastes in these regions. These companies have a strong presence in Europe and North America. They also have manufacturing facilities along with strong distribution networks across these regions.

  • Published: August 2021
  • Price: $ 4950
  • TOC Available:

• Drug Screening Market Size by Product (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)), Sample (Urine, Breath, Hair), Drug (Alcohol, Cannabis, Opioids), End User (Workplace, Hospital, Law) - Global Forecast to 2029

  The global drug screening market, valued at US$7.7 billion in 2023, stood at US$9.1 billion in 2024 and is projected to advance at a resilient CAGR of 16.6% from 2024 to 2029, culminating in a forecasted valuation of US$19.5 billion by the end of the period. The growth of the drug screening market is driven by the growing drug & alcohol consumption and the enforcement of stringent laws mandating drug & alcohol testing.

  • Published: May 2024
  • Price: $ 4950
  • TOC Available:

• HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030

  Global HIV diagnostics market valued at $2.96B in 2024, reached $3.25B in 2025, and is projected to grow at a robust 10.3% CAGR, hitting $ 5.31B by 2030. The HIV diagnostics market is driven by several key factors, such as the rising prevalence of HIV/AIDS, the increasing number of blood transfusions and blood donations, advantages offered by POC diagnostic kits & instruments, and the growing focus on initiatives for HIV awareness.

  • Published: February 2025
  • Price: $ 4950
  • TOC Available:

• COVID 19 Impact on IVD (In Vitro Diagnostics) Market by Technology (PCR, NGS, ELISA, Rapid Test, Hematology, Hemostasis, Clinical Chemistry, Microbiology Testing, Urinalysis), End-user and Region - Global Forecast to 2025

  The COVID 19 Impact on IVD (In Vitro Diagnostics) Market is expected to grow from USD 61.7 billion in 2020 to USD 77.9 billion by 2025, at a CAGR of 4.8% during the forecast period. As of 2019, some of the prominent players in the in-vitro diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Biomerieux (France), and QIAGEN (Germany), among others.

  • Published: May 2020
  • Price: $ 4950
  • TOC Available:

• Rapid Prototyping Materials Market by Type (Polymers, Metals, Ceramics), Form (Filament, Powder, Ink), Function (Conceptual, Functional Prototype), End User (Aerospace & Defense, Manufacturing & Construction, Healthcare) - Global Forecast to 2021

  The rapid prototyping materials market was valued at USD 217.5 Million in 2015 and is projected to reach USD 903.8 Million by 2021, at a CAGR of 26.8% between 2016 and 2021. Major factors driving the growth of the rapid prototyping materials market include high demand for product modification and development, low cycle time of printing, expected increase in supply capacity with forward integration, and development of application-specific grades.

  • Published: August 2016
  • Price: $ 4950
  • TOC Available:

• RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test (Immunofluorescence Assay, ELISA), Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) & Region

  The global RSV diagnostics market is expected to grow at a CAGR of 10.1%. Market growth is primarily driven by the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. Key players in the RSV diagnostics market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).

  • Published: February 2018
  • Price: $ 4950
  • TOC Available:

• Rapid Microbiology Testing Market by Product (Instruments (Automated Identification System, PCR, Mass Spectrometer) Reagent, Kits), Method (Growth, Nucleic Acid, Viability), Application (Clinical Diagnosis, Industrial, Research) & Region - Global Forecast to 2029

  The global rapid microbiology testing market, valued at US$4.7 billion in 2023, stood at US$5.1 billion in 2024 and is projected to advance at a resilient CAGR of 10.1% from 2023 to 2029, culminating in a forecasted valuation of US$8.3 billion by the end of the period.The increasing use of rapid microbiology testing products can be attributed to their ability to provide quick and reliable results. These products are cost-effective and can often lead to cost savings compared to traditional methods, which is a significant factor driving market growth.

  • Published: April 2024
  • Price: $ 4950
  • TOC Available:

• Rolling Stock Market by Component, Product Type (Locomotive, Rapid Transit, Coach), Locomotive Technology (Conventional, Turbocharged, Maglev), Application (Passenger Transportation, Freight Transportation) and Region - Global Forecast to 2032

  The rolling stock market is projected to grow from USD 30.94 billion in 2025 to USD 41.79 billion by 2032, at a CAGR of 4.4%. Some of the major players in the rolling stock market with significant global presence include CRRC Corporation Limited (China), Siemens AG (Germany), Alstom SA (France), Stadler Rail AG (Switzerland), and Wabtec Corporation (US).

  • Published: October 2025
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50